期刊文献+

无创正压通气联合甲泼尼龙 异丙托溴铵治疗重症哮喘伴呼吸衰竭疗效观察 被引量:1

Observation on the curative effect of non-invasive positive pressure ventilation combined with methylprednisolone and ipratropium bromide in the treatment of severe asthma with respiratory failure
下载PDF
导出
摘要 目的探讨无创正压通气联合甲泼尼龙、异丙托溴铵治疗重症哮喘伴呼吸衰竭的临床疗效及对患者肺功能及血气指标的影响。方法将150例重症哮喘伴呼吸衰竭患者按随机数字表法分为两组,每组75例。两组予以常规治疗及无创正压通气治疗,观察组在此基础上联合甲泼尼龙及异丙托溴铵治疗,观察7 d。比较两组临床疗效、不良反应发生状况,治疗前后肺功能(用力肺活量、呼气流量峰值)、血气指标(动脉血二氧化碳分压、动脉血氧分压)。结果观察组治疗总有效率显著高于对照组(P<0.05)。治疗后观察组用力肺活量、呼气流量峰值及动脉血氧分压均显著高于对照组(P<0.05),动脉血二氧化碳分压显著低于对照组(P<0.05)。治疗期间两组均未出现明显不良反应。结论无创正压通气联合甲泼尼龙、异丙托溴铵治疗重症哮喘伴呼吸衰竭疗效较好,能明显改善患者肺功能及血气指标,安全性高。 Objective To explore the clinical efficacy of non-invasive positive pressure ventilation combined with methylprednisolone and ipratropium bromide in the treatment of severe asthma(SA)with respiratory failure(RF)and its influence on patients'lung function and blood gas indexes.Methods A total of 150 SA patients with RF were divided into two groups according to random number table method,with 75 cases in each group.Both groups were given conventional treatment and NIPPV.The observation group was treated with methylprednisolone and ipratropium bromide on this basis for 7 days.The clinical efficacy,adverse reactions,lung function[forced vital capacity(FVC),peak expiratory flow(PEF)]and blood gas indexes[partial pressure of carbon dioxide in artery(PaCO_(2)),arterial blood oxygen partial pressure(PaO_(2))]were compared between the two groups before and after treatment.Results The total effective rate of treatment in the observation group was significantly higher than that in the control group(P<0.05).After treatment,FVC,PEF and PaO_(2) in the observation group were significantly higher than those in the control group(P<0.05),and PaCO_(2) was significantly lower than that in the control group(P<0.05).There were no obvious adverse reactions in both groups during treatment.Conclusions NIPPV combined with methylprednisolone and ipratropium bromide is effective in the treatment of severe asthma with respiratory failure.It can significantly improve the lung function and blood gas indexes of patients with high safety.
作者 李建领 雷军旗 安勇鹏 Li Jianling;Lei Junqi;An Yongpeng(Kaifeng Central Hospital,Kaifeng 475000,Henan,China)
机构地区 开封市中心医院
出处 《临床心身疾病杂志》 CAS 2021年第6期121-124,共4页 Journal of Clinical Psychosomatic Diseases
基金 开封市科技计划项目(编号2017610430)。
关键词 重症哮喘 呼吸衰竭 甲泼尼龙 异丙托溴铵 无创正压通气 肺功能 血气指标 severe asthma respiratory failure methylprednisolone ipratropium bromide NIPPV lung function blood gas index
  • 相关文献

二级参考文献113

  • 1李建生,余学庆,胡金亮,程龙.中医证候标准建立的思路与方法[J].河南中医学院学报,2004(6):4-6. 被引量:96
  • 2周信英,王世荣,沈新,何国芳,秦义倩.布地奈德联合全乐宁、博利康尼雾化吸入治疗儿童哮喘急性发作疗效分析[J].武警医学院学报,2005,14(1):51-52. 被引量:1
  • 3吕福祯,鲍永霞,邵玉霞.慢性阻塞性肺疾病患者与吸烟者的运动心肺功能对比研究[J].中国呼吸与危重监护杂志,2005,4(2):122-125. 被引量:22
  • 4中华中医药学会.中医内科常见病诊疗指南·中医病证部分[M].北京:中国中医药出版社,2008:39-42.
  • 5全国科学技术名词审定委员会.中医药学名词[M].北京:科学出版社,2005.81.
  • 6国家技术监督局.中医临床诊疗术语[S].北京:中国标准出版社.1997.1-41.
  • 7贝政平.内科疾病诊断标准[M].2版,北京:科学出版社,2007:725-726.
  • 8中华中医药学会.中医内科常见病诊疗指南·两医疾病部分[M].北京:中国中医药出版社,2008:80-82.
  • 9王至婉,李建生,李素云,等.慢性呼吸衰竭证候诊断的专家问卷调查分析[C]//世界中医药学会联合会内科专业委员会.世界中医药学会联合会内科专业委员会成立大会暨首届国际中医内科学术论坛论文集.北京,2011:190-193.
  • 10李建生,王至婉,李素云,等.慢性呼吸衰竭的中医证候诊断标准研制[C]//中华中医药学会肺系病分会.中华中医药学会肺系病分会成立大会第十五次全国中医肺系病学术交流大会论文集.北京,2011:337-339.

共引文献387

同被引文献10

引证文献1

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部